Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire. Damaj, G; Mohty, M; Robin, M; Michallet, M; Chevallier, P; Beguin, Y; Nguyen, S; Bories, P; Blaise, D; Maillard, N; Rubio, M.; Fegueux, N; Cornillon, J; Clavert, A; Huynh, A; Adès, L; Thiébaut-Bertrand, A; Hermine, O; Vigouroux, S; Fenaux, P; Duhamel, A; and Yakoub-Agha, I Biol Blood Marrow Transplant, 20:1349–55, 2014.
doi bibtex

@article{damaj_upfront_2014,
	title = {Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome: a study by the {Société} {Française} de {Greffe} de {Moelle} et de {Thérapie} {Cellulaire}.},
	volume = {20},
	issn = {1523-6536},
	doi = {10.1016/j.bbmt.2014.05.010},
	language = {English},
	journal = {Biol Blood Marrow Transplant},
	author = {Damaj, G and Mohty, M and Robin, M and Michallet, M and Chevallier, P and Beguin, Y and Nguyen, S and Bories, P and Blaise, D and Maillard, N and Rubio, MT and Fegueux, N and Cornillon, J and Clavert, A and Huynh, A and Adès, L and Thiébaut-Bertrand, A and Hermine, O and Vigouroux, S and Fenaux, P and Duhamel, A and Yakoub-Agha, I},
	year = {2014},
	pages = {1349--55}
}

Downloads: 0